MCC 2024

Dr. med. Federica Bianchi

HUG - Division Médicine Palliative

SCIENTIFIC COLLABORATOR – FAHPA, February 2022

• Clinical Trial Manager and medical writer 50%
• Develop and coordinate a randomized clinical trial (RCT): A formulation of THC/CBD oil for behavioural symptoms in patients with severe dementia.
• Manuscript publication and communication
• Data analysis

SCIENTIFIC COLLABORATOR – HUG, November 2021

• Research Coordinator 10%

• Coordination and implementation of research projects in support of the Palliative Care Division
• Clinical Trial Coordinator and Pharmacist (ended April 30, 2022)

• Development of the RCT on medical cannabis and preparation of trial documents

Experiences

SCIENTIFIC COLLABORATOR – MAS PROGRAM, May 2021-Nov 2021

• Training in the framework of the MAS Drug Discovery and Clinical Development

Trail coordinator and medical writer: Initiation of the RCT design and the data analysis of the observational trial
MEDICAL WRITER – Independent 2019-2020
• Writing scientific articles
• Advisory board reports
• Online Blogs
• Online information platforms

Areas of expertise: Microbiome, Allergies, Natural products
I have collaborated with Helvet Health and Microbioma.it in the writing of scientific articles, the vulgarization of articles and scientific communication to health professionals

Education
• University of Geneva – 2022 MAS Drug Discovery and Clinical Management.
• Thesis: Randomized, double-blind, placebo-controlled trial to investigate the impact on behavioral and psychological symptoms of dementia (BPSD) of medical cannabinoids (CBD/THC 2:1) in patients with severe dementia in long-term care facilities in Geneva
• Winner of the best MAS thesis work
• Polytechnic University of Marche – 2010 master’s in nutrition and dietetics cum Laude. Thesis: Food allergies and intolerances: the enigma of our time
• University of Eastern Piedmont Amedeo Avogadro – 2004 PhD in chemistry of bioactive substances. Thesis: Bioactive compounds from plants. Identification and structure-activity relationships of new anti-infectious and anti-inflammatory leads
• University of Turin – 2000 master’s in pharmacy cum Laude